Literature DB >> 18437281

Neither single-marker nor haplotype analyses support an association between monoamine oxidase A gene and bipolar disorder.

San-Yuan Huang1, Ming-Teng Lin, Mee-Jen Shy, Wei-Wen Lin, Fang-Yi Lin, Ru-Band Lu.   

Abstract

Monoamine oxidase A (MAOA) abnormality has been suggested as a crucial factor in the pathogenesis of mood disorder, because MAOA is associated with the metabolism of monoamines such as serotonin and norepinephrine. Various MAOA gene polymorphisms have been investigated for possible associations with bipolar disorder (BD), but the results are controversial. Our goal was to investigate whether MAOA gene polymorphisms, especially the promoter uVNTR polymorphism and the EcoRV polymorphism, are associated either with BD or with different clinical subtypes of BD. A total of 714 Han Chinese subjects in Taiwan (305 controls and 409 BD patients) were recruited for study. All subjects were interviewed with the Chinese Version of the Modified Schedule of Affective Disorders and Schizophrenia-Lifetime; BD was diagnosed according to DSM-IV criteria. Genotyping for MAOA polymorphisms was performed using PCR and restriction fragment length polymorphism. The MAOA promoter polymorphisms uVNTR and EcoRV were not associated with BD or any of its subtypes, in either the frequencies of alleles or genotypes. In multiple logistic regression and haplotype frequency analysis, we confirmed these negative results in both females and males. Our results suggest that MAOA polymorphisms do not play a major role in pathogenesis of BD or its clinical subtypes in Han Chinese.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18437281     DOI: 10.1007/s00406-008-0803-1

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  55 in total

1.  Screening for bipolar disorder in a primary care practice.

Authors:  Amar K Das; Mark Olfson; Marc J Gameroff; Daniel J Pilowsky; Carlos Blanco; Adriana Feder; Raz Gross; Yuval Neria; Rafael Lantigua; Steven Shea; Myrna M Weissman
Journal:  JAMA       Date:  2005-02-23       Impact factor: 56.272

2.  A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder.

Authors:  Leo Sher; Juan J Carballo; Michael F Grunebaum; Ainsley K Burke; Gil Zalsman; Yung-yu Huang; J John Mann; Maria A Oquendo
Journal:  Bipolar Disord       Date:  2006-10       Impact factor: 6.744

Review 3.  The catecholamine hypothesis of affective disorders: a review of supporting evidence.

Authors:  J J Schildkraut
Journal:  Am J Psychiatry       Date:  1965-11       Impact factor: 18.112

4.  Reduced dopamine turnover in the basal ganglia of depressed suicides.

Authors:  C Bowden; S C Cheetham; S Lowther; C L Katona; M R Crompton; R W Horton
Journal:  Brain Res       Date:  1997-09-19       Impact factor: 3.252

Review 5.  Family, twin, adoption, and molecular genetic studies of juvenile bipolar disorder.

Authors:  Robert R Althoff; Stephen V Faraone; David C Rettew; Christopher P Morley; James J Hudziak
Journal:  Bipolar Disord       Date:  2005-12       Impact factor: 6.744

6.  A functional polymorphism in the promoter region of monoamine oxidase-A gene and mood disorders.

Authors:  H Kunugi; S Ishida; T Kato; M Tatsumi; T Sakai; M Hattori; T Hirose; S Nanko
Journal:  Mol Psychiatry       Date:  1999-07       Impact factor: 15.992

7.  Impact of bipolar disorder on a U.S. community sample.

Authors:  Joseph R Calabrese; Robert M A Hirschfeld; Michael Reed; Marilyn A Davies; Mark A Frye; Paul E Keck; Lydia Lewis; Susan L McElroy; James P McNulty; Karen D Wagner
Journal:  J Clin Psychiatry       Date:  2003-04       Impact factor: 4.384

8.  Gene-environment interaction analysis of serotonin system markers with adolescent depression.

Authors:  T C Eley; K Sugden; A Corsico; A M Gregory; P Sham; P McGuffin; R Plomin; I W Craig
Journal:  Mol Psychiatry       Date:  2004-10       Impact factor: 15.992

9.  Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.

Authors:  Avshalom Caspi; Karen Sugden; Terrie E Moffitt; Alan Taylor; Ian W Craig; HonaLee Harrington; Joseph McClay; Jonathan Mill; Judy Martin; Antony Braithwaite; Richie Poulton
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

10.  Neither antisocial personality disorder nor antisocial alcoholism is associated with the MAO-A gene in Han Chinese males.

Authors:  Ru-Band Lu; Wei-Wen Lin; Jia-Fu Lee; Huei-Chen Ko; Jean Chen Shih
Journal:  Alcohol Clin Exp Res       Date:  2003-06       Impact factor: 3.455

View more
  3 in total

1.  MAOA Variants and Genetic Susceptibility to Major Psychiatric Disorders.

Authors:  Zichao Liu; Liang Huang; Xiong-Jian Luo; Lichuan Wu; Ming Li
Journal:  Mol Neurobiol       Date:  2015-07-31       Impact factor: 5.590

2.  Monoamine oxidase a gene polymorphisms and bipolar disorder in Iranian population.

Authors:  Mohammad Reza Eslami Amirabadi; Sepideh Rajezi Esfahani; Rozita Davari-Ashtiani; Mojgan Khademi; Babak Emamalizadeh; Abolfazl Movafagh; Said Sadr; Fariba Arabgol; Hossein Darvish; Katayoon Razjoyan
Journal:  Iran Red Crescent Med J       Date:  2015-02-21       Impact factor: 0.611

3.  Methylation of the MAOA promoter is associated with schizophrenia.

Authors:  Hao Yang; Jiajue Li; Aicen Ji; Liping Hu; Xiufeng Zhang; Linlin Liu; Lili Qing; Ming Yan; Shengjie Nie
Journal:  Ann Transl Med       Date:  2020-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.